Also trades as: APLM (NASDAQ) · $vol 0M
APLMW NASDAQ
Apollomics, Inc.
1W: -19.4%
1M: -4.3%
3M: -11.3%
YTD: +0.8%
1Y: +33.0%
3Y: -85.4%
$0.01
-0.00 (-1.36%)
Weekly Expected Move ±24.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$214.3M
52W Range0.0063-0.026
Volume499,475
Avg Volume88,928
Beta2.26
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGuo-Liang Yu
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2023-03-30
Websiteapollomicsinc.com
989 East Hillsdale Blvd
Foster City, CA
US
Foster City, CA
US
650 209 4055
About Apollomics, Inc.
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Latest News
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Apollomics Inc. Announces $2.0 Million Bridge Financing
Apollomics Inc. Announces $2.0 Million Bridge Financing
Apollomics Reports First Half 2025 Financial Results
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Chen Hung-Wen | 0 | — | 2026-03-19 | |
| Chen Hung-Wen | 0 | — | 2026-03-19 | |
| Chen Hung-Wen | 10,000 | — | 2026-03-19 | |
| CHEN HONG-JUNG | 0 | — | 2026-03-18 | |
| Jan Chen-Huan | 0 | — | 2026-03-18 |